| Date | Title | |
|---|---|---|
| 16 Feb 2026 |
Artios Pharma |
|
| 11 Feb 2026 |
Microbiotica Ltd Microbiotica announces impressive results in its Phase 1b trial of MB310 in Ulcerative Colitis |
|
| 05 Feb 2026 |
Quantum Motion Technologies Quantum Motion Expands Global Presence by Opening European Offices in Spain |
|
| 04 Feb 2026 |
Lumai Lumai appoints René Bonvanie as Chair of its Board of Directors |
|
| 03 Feb 2026 |
First Light Fusion Ltd First Light Fusion wins UKAEA contract to prove Natural Lithium Shielding concept |
|
| 14 Jan 2026 |
Accelercomm Ltd |
|
| 14 Jan 2026 |
Centessa Pharmaceuticals plc |
|
| 14 Jan 2026 |
OXCCU |
|
| 13 Jan 2026 |
First Light Fusion Ltd First Light Fusion achieves JOSCAR registration, strengthening trust and opening new opportunities |
|
| 12 Jan 2026 |
Oxford Nanopore Technologies Plc Oxford Nanopore Technologies plc - Full Year Trading Update and Notice of Results |
|
| Load more1165 | ||